Cytokine induction by extracellular products of oral viridans group streptococci.
AUTOR(ES)
Takada, H
RESUMO
During an etiological study of Kawasaki disease (mucocutaneous lymph node syndrome [MCLS]), we found that dominant viridans streptococcal strains on tooth surfaces and in the throat of both MCLS patients and non-MCLS control children formed erythrogenic and biologically active, extracellular products. In this study, we demonstrated that erythrogenic culture supernatant concentrates of representative strains (two Streptococcus mitis and two Streptococcus oralis), when injected intravenously, induced serum tumor necrosis factor alpha, interleukin-6 (IL-6), and gamma interferon in muramyldipeptide- or Propionibacterium acnes-primed C3H/HeN mice. The concentrates also induced tumor necrosis factor alpha, IL-6, and thymocyte-activating factor (essentially IL-1) in murine peritoneal macrophage, human monocyte, and human whole-blood cultures. An erythrogenic, heat-labile extracellular protein fraction (F-1) that was concentrated from the culture supernatants of a representative S. mitis strain exhibited the above-mentioned cytokine-inducing activity. This partially purified F-1 fraction also induced thymocyte-activating factor and IL-6 in human umbilical vascular endothelial cell and gingival fibroblast cultures.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=281309Documentos Relacionados
- Mechanisms of platelet aggregation by viridans group streptococci.
- Extracellular neuraminidase production by group B streptococci.
- Role of immunoglobulin G in platelet aggregation by viridans group streptococci.
- Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci.
- Association of cell-adherent glycocalyx and endocarditis production by viridans group streptococci.
